MedTrace Logo

Bivalirudin as a Procedural Anticoagulant in Pediatrics

NCT00503126 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2011-11-10

No results posted yet for this study

Summary

Pharmacokinetics and safety of weight based bivalirudin in children

Conditions

  • Cardiology

Interventions

DRUG

bivalirudin

anticoagulation

Sponsors & Collaborators

  • The Medicines Company

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2008-07-31
Completion
2008-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00503126 on ClinicalTrials.gov